3Sun-Lung Tsai MD, PhD,I-Shyan Sheen,Rong-Nan Chien,Chia-Min Chu,Hsiu-Chu Huang,Yen-Ling Chuang,Tzong-Hsien Lee,Shuen-Kuei Liao,Chen-Lung Lin,George C. Kuo,Yun-Fan Liaw. Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: Tetramer assay and therapeutic implications[J] 2003,Journal of Biomedical Science(1):120～135
8Shen HD, Choo KB, Lee SD. Hepatitis B virus DNA in leukocytes of patients with hepatitis B virus-associated liver diseases. J Med Virol 1986; 18:201-211.
9Baroja ML, Sirit FL, Caldera DJ, Toro FI, Zabaleta ME, Colmenares CJ, Blanco NE, Machado W. Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signals. Clin Immunol Immunopathol 1993; 69:180-188.
10Chu CM, Liaw YF. Peripheral T-cell subsets in asymptomatic hepatitis B-virus carriers. Cell Immunol 1986; 98:533-537.
